NCT05288140 Efficacy of the Use of Diaries in Intensive Care Units
| NCT ID | NCT05288140 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Barcelona |
| Condition | Diary (Blank Journal) |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 240 participants in total. It began in 2022-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Randomized clinical trial that aims to evaluate the impact of the use of a diary in patients and relatives of patients admitted to an ICU in relation to usual practice in terms of health-related quality of life, the post-traumatic stress and anxiety/depression at 2, 6 and 12 months after ICU discharge.
Eligibility Criteria
Inclusion Criteria: * admitted intensive care unit * sedated and mechanically ventilated for 24hours * signed consent * not language barrier * willingness to attend follow-up visits Exclusion Criteria: * verbal manifestation of psychiatric, mental or cognitive antecedents * who do not coluntarily agree to participate
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05288140 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Diary (Blank Journal). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05288140 currently recruiting?
Yes, NCT05288140 is actively recruiting participants. Contact the research team at mpmunozr.germanstrias@gencat.cat for enrollment information.
Where is the NCT05288140 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT05288140 clinical trial?
NCT05288140 is sponsored by University of Barcelona. The trial plans to enroll 240 participants.